Bacterial Infections: all 665 studies

Page 6 of 7. Open to participants first (99), then studies with results posted, then the rest; newest registration first within each.

• Pharmacokinetics and Safety of Solithromycin Capsules in AdolescentsCompletedNCT01966055Phase 1
• A Pharmacokinetics, Pharmacodynamics, and Safety Study of an Oral Contraceptive Containing Norethindrone and Ethinyl Estradiol When Co-administered With GSK1322322 in Healthy Adult WomenWithdrawnNCT01953809Phase 1
• TD-1607 MAD Study in Healthy SubjectsCompletedNCT01949103Phase 1
• A Single Dose Study To Investigate The Pharmacokinetics and Safety Of Dalbavancin In Hospitalized Children Aged 3 Months to 11 Years.CompletedNCT01946568Phase 1
• To Evaluate Plasma and Pulmonary Pharmacokinetics of GSK2140944CompletedNCT01934205Phase 1
• Prospective Study to Optimize Vancomycin Dosing in Children and Adults Using Computer SoftwareCompletedNCT01932034
• Resistance of Helicobacter Pylori to Antibiotics in ChildrenCompletedNCT01902589
• The Impact of Helicobacter Pylori Infection on Immune Regulation and Clinical Course in HIV Patients in GhanaCompletedNCT01897909
• Safety, Tolerability, Pharmacokinetics of Intravenous RPX2014 and RPX7009 in Healthy Adult SubjectsCompletedNCT01897779Phase 1
• Preventing Bacterial and Viral Infections Among Injection Drug UsersCompletedNCT01892358Not applicable
• Multicentric Study About the Usefulness of Monitoring Plasma Levels of Colistin and Sodium Colistimethate in Patients With Infections Due to Multi-drug Resistant Gram Negative Bacilli, Treated With ColistinCompletedNCT01845246Not applicable
• Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster VaccinationCompletedNCT01839175Phase 3
• Bacterial Colonization in COPD in View of CAT Under ICS+LABA TherapyCompletedNCT01819298
• A Three-part Study to Determine the Safety, Tolerability and Pharmacokinetics of GSK1322322 in Healthy Volunteers and Healthy Male Japanese SubjectsTerminatedNCT01818011Phase 1
• Retapamulin Microdialysis Feasibility StudyCompletedNCT01812382Phase 1
• A Study to Evaluate the Effect of GSK1322322 on Cardiac Conduction as Assessed by 12-lead Electrocardiogram in Healthy VolunteersWithdrawnNCT01803399Phase 1
• Characterizing and Comparing the Profile of Microorganisms From Specific Body Sites and Environmental Surfaces in Newly Disinfected Patient RoomsCompletedNCT01803100
• Prevention of Bacterial Infections in NewbornCompletedNCT01800942Phase 3
• Milk Ingredients and Resistance Against E-coli-induced GastroEnteritis (MIRAGE)CompletedNCT01800396Not applicable
• Study Evaluating the Association of Antibiotic Measures and Control of Bacterial ResistanceCompletedNCT01788449
• Infant Antibiotic Resistance and Implications for Therapeutic Decision-makingCompletedNCT01781182
• Safety Study of Intravenous Biapenem (RPX2003) and RPX7009 Given Alone and in CombinationCompletedNCT01772836Phase 1
• Safety, Tolerability, Pharmacokinetics of Intravenous RPX7009 in Healthy Adult SubjectsCompletedNCT01751269Phase 1
• Safety & Efficacy of an Antibacterial Protein Molecule Applied Topically to the Nostrils of Volunteers and PatientsCompletedNCT01746654Phase 1/2
• Multicenter Open-label Randomized Controlled Trial (RCT) to Compare Colistin Alone Versus Colistin Plus MeropenemCompletedNCT01732250Phase 4
• The Effect of Probiotics on E. Coli-induced GastroenteritisCompletedNCT01709266Not applicable
• Safety, Tolerability, Pharmacokinetics of Intravenous RPX2003 (Biapenem) in Healthy Adult SubjectsCompletedNCT01702649Phase 1
• A Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C -GSK1322322 After an Intravenous and an Oral DoseCompletedNCT01663389Phase 1
• A Study to Assess the Relative Bioavailability of Three Formulations and Food Effect on GSK1322322 in Healthy SubjectsCompletedNCT01648179Phase 1
• 300 Antibody Diagnostic Test KitStatus unknownNCT01646411
• Study of Complication Rates Associated With PICC for Left vs RightCompletedNCT01638702Not applicable
• Contribution of Real Time Analyses of CARdio-RESpiratory Signals to the Diagnosis of Infection in PREterM InfantsCompletedNCT01611740
• A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Oral and Intravenous GSK1322322 in Healthy SubjectsCompletedNCT01610388Phase 1
• Evaluation of Extended Intravenous of Beta-lactams in the Treatment of Serious Gram-negative Infections in Critically Ill PatientsStatus unknownNCT01600768Not applicable
• Helicobacter Pylori and the Long-term Risk of Peptic Ulcer BleedingCompletedNCT01591486
• Hospital Wide Roll-Out of Antimicrobial StewardshipCompletedNCT01587937Not applicable
• WEUKBRE5555: IMI PROTECT(Work Package 2): Liver Injury & AntibioticsCompletedNCT01587768
• Safety of the Co-administration of Three Drugs for Trachoma and Lymphatic Filariasis EliminationCompletedNCT01586169Not applicable
• Increased Re-eradication Rate of Helicobacter Pylori by Adding N-acetylcystein or Metronidazole to the Triple TherapyStatus unknownNCT01572597Phase 4
• A Study of Safety, Tolerability, and Efficacy of AFN-12520000 in the Treatment of Acute Bacterial Skin and Skin Structure Infections Due to StaphylococciCompletedNCT01519492Phase 2
• Helicobacter Eradication Aspirin TrialCompletedNCT01506986Phase 4
• Retrospective Examination of Initial Care of Severe Bacterial Infections of the ChildCompletedNCT01485705Not applicable
• ALTARGO(Retapamulin) PMS(Post-marketing Surveillance)CompletedNCT01445600
• To Evaluate the Effectiveness(Immunogenicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy ChildrenCompletedNCT01402713Phase 2/3
• A Study of Doripenem in Infants Less Than 12 Weeks of AgeCompletedNCT01381848Phase 1
• Optimal Antibiotic Treatment of Moderate to Severe Bacterial InfectionsCompletedNCT01338116Not applicable
• Meropenem Plasma Concentration Measurements at the Pediatric Medical Ward, Oslo University Hospital, RikshospitaletCompletedNCT01289249
• Pulmonary Disposition of TR-700 Following Once-Daily Oral 200 mgCompletedNCT01271998Phase 1
• A Randomized, Single Blind, Placebo Controlled Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Oral Doses and Repeat Escalating Oral Doses of GSK2251052 in Healthy Adult SubjectsCompletedNCT01262885Phase 1
• Study of Chimeric Monoclonal Antibodies to Shiga Toxins 1 and 2CompletedNCT01252199Phase 2
• Neutrophil CD64 and Procalcitonin as Novel Biomarkers for Postoperative InfectionsCompletedNCT01250574
• Postoperative Antibiotic Requirements Following Immediate Breast ReconstructionCompletedNCT01244698Phase 4
• The Effect of Probiotics on E. Coli GastroenteritisCompletedNCT01225042Not applicable
• Daptomycin Pharmacokinetics in Critically Ill Patients Undergoing Continuous Veno-venous Hemodiafiltration, a Dose Finding StudyStatus unknownNCT01212432Phase 2
• Assessment of the Efficacy of FOSFOMYCIN in Patients With Bacterial InfectionCompletedNCT01173575
• The Rate of C-reactive Protein (CRP) Increase as a Marker for Bacterial Infections in ChildrenStatus unknownNCT01159470
• Pharmacokinetic (PK) Study of Oral and IV TR-701 FA in Adolescent PatientsCompletedNCT01156077Phase 1
• United States Pharmacovigilence Retapamulin-PrescribingCompletedNCT01153880
• In Vitro Activity of Tigecycline Among Key Bacterial Pathogens Exhibiting Multidrug ResistanceSuspendedNCT01132417
• Changes in Microbiota and Iron Status After Iron Fortification of Complementary FoodsCompletedNCT01111864Not applicable
• Human Innate Immune Responses To Mycobacterial Aerodigestive Tract InfectionCompletedNCT01074775Not applicable
• Cerebral Antibiotics Distribution After Acute Brain InjuryCompletedNCT01059890Phase 1
• Relative Bioavailability Study Of Two Lincomycin Hydrochloride Hard Gelatinous CapsuleCompletedNCT01058824Phase 1
• A Single Center Four Part Study in Healthy Adult Subjects to Evaluate: the Safety, Tolerability and Pharmacokinetics of a Single Oral Dose and Repeat Escalating Oral Doses of GSK945237; the Effect of Linezolid on Hematology Safety Parameters; and the Effects of GSK945237 and Moxifloxacin on QTc.WithdrawnNCT01039610Phase 1
• Pharmacokinetics (PK) and Safety Evaluation of Daptomycin in Children Ages 3-24 Months With Proven or Suspected Gram-positive Infections or Peri-Operative Subjects Receiving Prophylactic AntibioticsCompletedNCT01019395Phase 1
• An Evaluation Of Three Dose Levels Of 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) In Healthy AdultsCompletedNCT01018641Phase 1
• Safety, Pharmacokinetics (PK) and Tolerability Study of a Novel Drug for Treatment of Bacterial InfectionsCompletedNCT01015014Phase 1
• Ascending Dose Pharmacokinetic (PK) and Absolute Bioavailability (BA)CompletedNCT00983255Phase 1
• Effects of MRSA Bactericidal Gel To Promote Healing and Eliminate MRSA in cSSTI Vancogel(TM)Status unknownNCT00945152Phase 2
• Experimental Phage Therapy of Bacterial InfectionsStatus unknownNCT00945087Not applicable
• Relative Bioavailability Study in Healthy SubjectsCompletedNCT00924911Phase 1
• Incidence of Antibiotic Resistant E.Coli in Patients Undergoing Repeat Prostate BiopsyCompletedNCT00915213
• A Repeat Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK1322322 in Healthy SubjectsCompletedNCT00896558Phase 1
• Early-Onset Sepsis Surveillance StudyCompletedNCT00874367
• Validation Study of Combined Positron Emission Tomography/Computer Tomography to Diagnose Infection and InflammationTerminatedNCT00835783
• Single Dose Escalation First Time in Human PK StudyCompletedNCT00828867Phase 1
• Procalcitonin for Predicting Serious Bacterial Infection in Infants Less Than 3 MonthsCompletedNCT00800488
• Mastering Hospital Antimicrobial Resistance and Its Spread Into the CommunityStatus unknownNCT00765778
• An Open Label Evaluation of the Pharmacokinetics and Safety of Single Dose Intravenous Azithromycin in Preterm NeonatesCompletedNCT00760279Phase 1
• What is the Prevalence of Methicillin-Resistant Staphylococcus Aureus in Skin and Soft Tissue Infections Presenting to the Emergency Departments of a Canadian Academic Health Care Center?CompletedNCT00736554
• Efficacy and Safety Study of Finafloxacin Used in Helicobacter Pylori Infected PatientsCompletedNCT00723502Phase 2
• Procalcitonin Level and Kinetics in Children With Bacterial InfectionsCompletedNCT00714402
• New Dosages of Inflammatory Markers for the Early Diagnosis of Nosocomial Bacterial Infections of the NewbornCompletedNCT00701948
• Impact of Procalcitonin on the Management of Children Aged 1 to 36 Month Presenting With a Fever Without a SourceCompletedNCT00692848Not applicable
• Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK580416TerminatedNCT00680485Phase 1
• Study Of Dalbavancin Drug Levels Achieved In Hospitalized Adolescents Who Are Receiving Antibiotic Therapy For Bacterial InfectionsCompletedNCT00678106Phase 1
• BAYQ3939, 1000 mg Tablet in Transrectal Needle Biopsies of the Prostate (TRNBP) - Infection ProphylaxisCompletedNCT00670215Phase 3
• Ciprofloxacin on Burned PatientsCompletedNCT00668044Phase 3
• Early Use of Polymyxin B Hemoperfusion in Abdominal SepsisCompletedNCT00629382Phase 4
• A Randomised Trial on the Saftely and Efficacy of GR270774 in the Treatment of Gram-negative Sepsis in AdultSuspendedNCT00563134Not applicable
• A Study of the Safety and Tolerability of V419 in Healthy Infants at 2,4, 6 and 12 to 14 Months of Age (V419-003)CompletedNCT00551915Phase 2
• A Study to Test the Safety and Effectiveness of an Investigational Vaccine in Infants (V419-002)CompletedNCT00551629Phase 2
• To Evaluate Safety, Tolerability, Pharmacokinetics, And Food Effect Of Single Doses Of GSK945237 In Healthy SubjectsCompletedNCT00517673Phase 1
• Prevention of Catheter-Associated Infection With the Skin Disinfectant Octenidine DihydrochlorideCompletedNCT00515151Phase 4
• A Study in Sepsis Patients With Renal FailureTerminatedNCT00511186Phase 2
• Safety of a Single Dose of 5 mg of hLF1-11 Given to Autologous Haematopoietic Stem Cell Transplant RecipientsCompletedNCT00509938Phase 1/2
• Oral Antibiotic Treatment at Home Instead of Intravenous Treatment in Hospital for Resistant Gram Positive InfectionsCompletedNCT00501150Not applicable
• Trial of Rapid Diagnostic Tests in Rural GhanaCompletedNCT00493922Phase 4
• Study Evaluation Tazocin InterventionCompletedNCT00488189Phase 4
• Tazocin Intervention StudyCompletedNCT00478855Phase 4

← Bacterial Infections overview